Veracyte (VCYT) Shares Outstanding (Weighted Average) (2012 - 2026)

Veracyte has disclosed Shares Outstanding (Weighted Average) across 15 years of filings, most recently posting $79.5 million for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $79.5 million, up 1.93% year-over-year; the trailing twelve-month figure through Mar 2026 was $79.5 million (up 1.93% YoY), and the FY2025 annual result was $78.6 million, up 2.74% from the prior year.
• Shares Outstanding (Weighted Average) came in at $79.5 million for Q1 2026 at Veracyte, up from $78.6 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $79.5 million in Q1 2026 to a low of $71.2 million in Q1 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $74.8 million (2024), against an average of $74.8 million.
• Across the five-year window, Shares Outstanding (Weighted Average) increased 12.47% in 2022 and climbed 1.16% in 2023, its largest moves.
• Veracyte's Shares Outstanding (Weighted Average) stood at $71.5 million in 2022, then advanced by 1.53% to $72.6 million in 2023, then advanced by 5.29% to $76.5 million in 2024, then climbed by 2.74% to $78.6 million in 2025, then climbed by 1.21% to $79.5 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $79.5 million (Q1 2026), $78.6 million (Q4 2025), and $78.7 million (Q3 2025), per Business Quant data.